tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BCAX Stock Latest News

Promising Data and Durable Responses Drive Buy Rating for Bicara Therapeutics
RatingsPromising Data and Durable Responses Drive Buy Rating for Bicara Therapeutics
4d ago
BCAX
Buy Rating for Bicara Therapeutics Inc. Driven by Promising Clinical Progress and Strong Financial Position
PremiumRatings
Buy Rating for Bicara Therapeutics Inc. Driven by Promising Clinical Progress and Strong Financial Position
7d ago
BCAX
Bicara Therapeutics Reports Strong Financial Position and Clinical Progress
PremiumCompany Announcements
Bicara Therapeutics Reports Strong Financial Position and Clinical Progress
7d ago
BCAX
Bicara Therapeutics price target raised to $48 from $47 at Stifel
PremiumThe Fly
Bicara Therapeutics price target raised to $48 from $47 at Stifel
7d ago
BCAX
Morning Movers: Nvidia slips following report of H20 chip shortage in China
PremiumThe Fly
Morning Movers: Nvidia slips following report of H20 chip shortage in China
8d ago
EQ
GME
Bicara Therapeutics reports Q4 EPS (39c), consensus (28c)
PremiumThe FlyBicara Therapeutics reports Q4 EPS (39c), consensus (28c)
8d ago
BCAX
Bicara Therapeutics sees cash runway into 1H29
Premium
The Fly
Bicara Therapeutics sees cash runway into 1H29
8d ago
BCAX
Bicara Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
Bicara Therapeutics management to meet with Cantor Fitzgerald
23d ago
BCAX
Bicara Therapeutics announces first patients dosed in FORTIFI-HN01 trial
PremiumThe Fly
Bicara Therapeutics announces first patients dosed in FORTIFI-HN01 trial
2M ago
BCAX
Bicara Therapeutics initiated with an Outperform at Wedbush
PremiumThe Fly
Bicara Therapeutics initiated with an Outperform at Wedbush
2M ago
BCAX
Bicara Therapeutics initiated with an Outperform at Wedbush
PremiumThe Fly
Bicara Therapeutics initiated with an Outperform at Wedbush
2M ago
BCAX
Bicara presents data from Phase 1/1b dose expansion cohort of ficerafusp alfa
PremiumThe Fly
Bicara presents data from Phase 1/1b dose expansion cohort of ficerafusp alfa
2M ago
BCAX
Bicara Therapeutics price target raised to $45 from $42 at H.C. Wainwright
PremiumThe FlyBicara Therapeutics price target raised to $45 from $42 at H.C. Wainwright
2M ago
BCAX
Bicara Therapeutics initiated with a Not Rated at Goldman Sachs
Premium
The Fly
Bicara Therapeutics initiated with a Not Rated at Goldman Sachs
4M ago
BCAX
Bicara Therapeutics Reports Strong IPO and Clinical Advancements
Premium
Company Announcements
Bicara Therapeutics Reports Strong IPO and Clinical Advancements
5M ago
BCAX
Bicara Therapeutics reports Q3 EPS ($1.60), consensus (46c)
PremiumThe Fly
Bicara Therapeutics reports Q3 EPS ($1.60), consensus (46c)
5M ago
BCAX
Bicara Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Bicara Therapeutics initiated with a Buy at Rodman & Renshaw
5M ago
BCAX
Five new option listings on October 29th
PremiumThe Fly
Five new option listings on October 29th
5M ago
BKV
KLC
Opening Day: Another trio of biotech IPOs make Friday debut
PremiumThe Fly
Opening Day: Another trio of biotech IPOs make Friday debut
6M ago
C
JPM
Bicara Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyBicara Therapeutics initiated with an Overweight at Cantor Fitzgerald
6M ago
MRK
BCAX
Bicara Therapeutics initiated with an Overweight at Morgan Stanley
Premium
The Fly
Bicara Therapeutics initiated with an Overweight at Morgan Stanley
6M ago
BCAX
MRUS
Bicara Therapeutics initiated with a Buy at Stifel
Premium
The Fly
Bicara Therapeutics initiated with a Buy at Stifel
6M ago
BCAX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >